BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7594593)

  • 1. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues.
    Shastri N; Serwold T; Gonzalez F
    J Immunol; 1995 Nov; 155(9):4339-46. PubMed ID: 7594593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
    Shastri N; Gonzalez F
    J Immunol; 1993 Apr; 150(7):2724-36. PubMed ID: 8454852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
    Serwold T; Shastri N
    J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes.
    Malarkannan S; Goth S; Buchholz DR; Shastri N
    J Immunol; 1995 Jan; 154(2):585-98. PubMed ID: 7814870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors.
    Goth S; Nguyen V; Shastri N
    J Immunol; 1996 Sep; 157(5):1894-904. PubMed ID: 8757307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
    J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
    Spörri R; Reis e Sousa C
    Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
    Lipford GB; Hoffman M; Wagner H; Heeg K
    J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor.
    Nalefski EA; Rao A
    J Immunol; 1993 May; 150(9):3806-16. PubMed ID: 7682584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
    Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
    J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes.
    Bergmann CC; Yao Q; Ho CK; Buckwold SL
    J Immunol; 1996 Oct; 157(8):3242-9. PubMed ID: 8871618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of MHC class I molecules with biosynthesized endoplasmic reticulum-targeted peptides is inefficient in insect cells and can be enhanced by protease inhibitors.
    Deng Y; Gibbs J; Bacík I; Porgador A; Copeman J; Lehner P; Ortmann B; Cresswell P; Bennink JR; Yewdell JW
    J Immunol; 1998 Aug; 161(4):1677-85. PubMed ID: 9712031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of class I-restricted epitope processing by local or distal flanking sequence.
    Yellen-Shaw AJ; Eisenlohr LC
    J Immunol; 1997 Feb; 158(4):1727-33. PubMed ID: 9029109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues.
    Griem P; Takahashi K; Kalbacher H; Gleichmann E
    J Immunol; 1995 Aug; 155(3):1575-87. PubMed ID: 7543525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
    Oukka M; Riché N; Kosmatopoulos K
    J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
    Diment S
    J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.